// App-Quantinova.ai

126 : Validation of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and Effectiveness of Infliximab in the Treatment of Ankylosing Spondylitis over 4 Years: The Canadian Experience

Researchers

Presenter

  • Denis Choquette

Principal Investigators

  • Majed Khraishi

  • Allen Lehman

  • May Shawi

  • William Bensen

  • Saeed Shaikh

  • Dalton Sholter

  • Maqbool Sheriff

  • Emmanouil Rampakakis

  • John Sampalis

  • Francois Nantel

  • Susan Otawa

Medical Centers

  • Nexus Clinical Research, St Johns, NF, Canada

  • Memorial University of Newfoundland, St. John's, NF, Canada

  • Department of Medicine, Hamilton,Canada

  • Nanaimo Regional General Hospital, Nanaimo, BC, Canada

  • Street Medical Group, Edmonton,Canada

  • St. Josephs Hospital, McMaster University, Hamilton, ON, Canada

  • Institute of Rhumatology of Montreal, Montreal,Canada

Locations

  • Canada

Companies

  • JSS Medical Research

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • golimumab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved